Comparative Efficacy of Tyrosine Kinase Inhibitors and Antibody–Drug Conjugates in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A Systematic Review and Network Meta-Analysis

SIMPLE SUMMARY: Comparisons between the efficacy of tyrosine kinase inhibitors (TKIs) and antibody–drug conjugates (ADCs) in treating HER2-positive breast cancer brain metastasis (BCBM) patients have not previously been conducted. We performed a systematic review and Bayesian-based network meta-anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan, Xu, Hangcheng, Han, Yiqun, Wu, Yun, Wang, Jiayu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321046/
https://www.ncbi.nlm.nih.gov/pubmed/35884431
http://dx.doi.org/10.3390/cancers14143372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321046/
https://www.ncbi.nlm.nih.gov/pubmed/35884431
http://dx.doi.org/10.3390/cancers14143372

Ejemplares similares